Home
Live
News
Create
Screeners
Insights
Supriya Lifescience
738.
60
+15.95
(+2.21%)
Market Cap
₹5,816.10 Cr
PE Ratio
33.39
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.21%
1M
+11.51%
6M
-0.92%
1Y
+32.75%
5Y
+88.97%
View Company Insights
Latest news about Supriya Lifescience
Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility, Expanding Global Reach
Oct 01, 2025
Supriya Lifescience Limited has obtained a Good Manufacturing Practices (GMP) certificate from the World Health Organization (WHO) for its Ambernath facility. The certification, issued after a GMP audit for Inhalation Dosages on September 2, 2025, allows the company to conduct global production and distribution operations. While the company doesn't expect immediate material impact on current business operations, the certification enhances its ability to expand into international markets and distribute products in Rest of the World markets.
Supriya Lifescience Sets Ambitious Growth Targets, Eyes US Market Expansion
Sep 01, 2025
Supriya Lifescience Faces ₹603.8 Crore Tax Demand
Jul 01, 2025
Supriya Lifescience Unveils Ambitious Growth Strategy, Targets ₹1,000 Crore Revenue by FY27
May 29, 2025
Supriya Lifescience Reports Strong Q4 Results, Announces Dividend
May 27, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation